U.S. stocks couldn't find their footing Wednesday, with technology stocks leading the retreat as investors rotated into energy names. The Nasdaq Composite bore the brunt of the selling pressure, dropping 1.18% to 22,838.26, while the Dow Jones Industrial Average showed more resilience, edging down just 0.13% to 48,050.79. The S&P 500 fell 0.73% to 6,750.66.
Sector Action: Energy Shines as Tech Stumbles
It was a tale of two markets Wednesday. Energy stocks jumped 1.3%, benefiting from a solid rally in crude oil prices. On the flip side, information technology stocks slumped 1.8%, making it the day's worst-performing sector and weighing heavily on the major indices.
General Mills Beats Expectations
General Mills Inc. (GIS) delivered a pleasant surprise, reporting second-quarter adjusted earnings of $1.10 per share, easily topping analyst estimates of $1.03. Revenue came in at $4.86 billion, down 7% year over year but still ahead of the Street's $4.781 billion forecast. The company maintained its fiscal 2026 outlook, signaling confidence in its trajectory.
Big Winners
Vyne Therapeutics Inc. (VYNE) rocketed 57% to $0.63 after announcing a definitive merger agreement with Yarrow Bioscience. The deal sparked enthusiasm among investors betting on synergies between the two companies.
Udemy Inc. (UDMY) surged 27% to $6.80 following news that Coursera signed an all-stock merger agreement with the online learning platform. The combination creates a powerhouse in the digital education space.
DBV Technologies SA - ADR (DBVT) climbed 28% to $23.09 after reporting that its Phase 3 VITESSE trial met its primary endpoint. The positive clinical data sent shares soaring as investors reassessed the company's pipeline potential.
Notable Decliners
Vistagen Therapeutics Inc. (VTGN) crashed 81% to $0.81 after revealing that its PALISADE-3 Phase 3 study failed to achieve its primary endpoint. The disappointing trial results essentially wiped out most of the company's market value in a single session.
Children's Place Inc. (PLCE) tumbled 39% to $4.46 after reporting third-quarter results that fell short of expectations. The struggling retailer continues to face headwinds in a challenging consumer environment.
Kyverna Therapeutics Inc. (KYTX) dropped 32% to $7.00 following the announcement of a $100 million public offering of common stock. The dilutive capital raise spooked existing shareholders.
Commodities Rally Across the Board
Commodity markets showed broad strength Wednesday. Crude oil climbed 1.7% to $56.21 per barrel, while gold advanced 0.9% to $4,371.80. Silver posted an impressive 4.6% gain to $66.205, and copper rose 1.4% to $5.4340.
Global Markets
European markets mostly finished in positive territory. The eurozone's STOXX 600 gained 0.39%, while London's FTSE 100 jumped 1.60%. Germany's DAX 40 edged up 0.04%, France's CAC 40 slipped 0.03%, and Spain's IBEX 35 rose 0.28%.
Asian markets closed mostly higher Wednesday. Japan's Nikkei gained 0.26%, Hong Kong's Hang Seng climbed 0.92%, and China's Shanghai Composite rose 1.19%. India's BSE Sensex was the outlier, falling 0.14%.
Economic Data
Mortgage applications declined 3.8% in the week ended December 12, reversing the previous period's 4.8% increase. The pullback suggests some cooling in housing market activity.
U.S. crude oil inventories fell by 1.274 million barrels in the week ended December 12, compared to a 1.812 million barrel decline the prior week. The drawdown slightly exceeded market expectations of a 1.1 million barrel drop, providing support for oil prices.




